Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Israel / NCT04603196
Recruiting Observational

Prevalence and Impact of Obstructive Sleep Apnea in Multiple Sclerosis

NCT04603196 · tracked via the Priya Life Science Israel tracker
Sponsor
Beth Israel Deaconess Medical Center
Phase
Observational
Started
2019-06-20
Last updated
2026-05-11

Condition(s) studied

Multiple SclerosisObstructive Sleep Apnea

Study summary

This study will evaluate the influence of sleep apnea on clinical and radiological features of MS. Sleep apnea is associated with hypoxemia during sleep, which is likely detrimental to MS. Clinical data (MRI, lab results, medical history, labs, and sleep studies) of MS patients will be collected and analyzed. This will be done to study correlations between MRI, clinical data, lab studies and sleep studies. There is specific interest in the type of sleep apnea associated with MS, and whether MRI or clinical metrics of MS severity correlate with presence or absence of sleep apnea.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Written consent * Over age 18 * Confirmed diagnosis of multiple sclerosis Exclusion Criteria: * cannot provide informed consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Beth Israel Deaconess Medical Center Boston Massachusetts Recruiting

More Beth Israel Deaconess Medical Center trials in Israel

Statins In Intracerbral Hemorrhage Recruiting
Mechanical Ventilator Adjustments and Patient Dyspnea Starting soon
TRAjectories and CLinical ExpeRiences of ICD Therapy Study Enrolling by invitation
Remote Fetal Monitoring in High Risk Pregnancies Recruiting
CEReBral AutorEgulation in Non-cardiac SuRgery and Relationship to Postoperative DeliriUm State Recruiting

Other trials for the same condition

A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis Active, not recruiting
The Effect of a Mediterranean Diet on Quality of Life in Multiple Sclerosis Patients Recruiting
Biobank For MS And Other Demyelinating Diseases Active, not recruiting
Implementation of an Advanced Telerehabilitation Solution for People With Multiple Sclerosis Starting soon
3D Printer Modified CPAP Mask for Obstructive Sleep Apnea Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04603196 on ClinicalTrials.gov ↗ ← All trials in Israel